Total Payments
$10,361
2024 Payments
$3,320
Companies
25
Transactions
675
Medicare Patients
1,211
Medicare Billing
$168,147
Payment Breakdown by Category
Food & Beverage$10,140 (97.9%)
Education$220.90 (2.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,140 | 668 | 97.9% |
| Education | $220.90 | 7 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,607 | 98 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $1,561 | 110 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $956.95 | 65 | $0 (2024) |
| Alkermes, Inc. | $873.47 | 55 | $0 (2024) |
| ITI, Inc. | $778.35 | 54 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $741.65 | 38 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $684.50 | 32 | $0 (2024) |
| Lundbeck LLC | $631.55 | 44 | $0 (2024) |
| Axsome Therapeutics, Inc. | $557.52 | 33 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $441.34 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,320 | 209 | Neurocrine Biosciences, Inc. ($435.90) |
| 2023 | $3,149 | 185 | Teva Pharmaceuticals USA, Inc. ($471.83) |
| 2022 | $2,336 | 170 | Neurocrine Biosciences, Inc. ($548.35) |
| 2021 | $1,557 | 111 | AbbVie Inc. ($420.97) |
All Payment Transactions
675 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $8.75 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $30.88 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: CNS | ||||||
| 12/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $5.79 | General |
| Category: Neuropsychiatry | ||||||
| 12/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: CNS | ||||||
| 12/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.47 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $1.10 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Neuroscience | ||||||
| 11/27/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $17.03 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.97 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Neuropsychiatry | ||||||
| 11/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.46 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $1.48 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: CNS | ||||||
| 11/12/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $1.42 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/11/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 245 | 668 | $125,250 | $44,461 |
| 2022 | 7 | 355 | 729 | $139,631 | $51,473 |
| 2021 | 6 | 331 | 595 | $112,118 | $43,210 |
| 2020 | 6 | 280 | 467 | $88,083 | $29,003 |
Total Patients
1,211
Total Services
2,459
Medicare Billing
$168,147
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 141 | 478 | $90,342 | $32,062 | 35.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 64 | 146 | $18,980 | $7,515 | 39.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 44 | $15,928 | $4,884 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 157 | 434 | $82,026 | $31,128 | 37.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 66 | 157 | $20,410 | $7,217 | 35.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 45 | 47 | $17,014 | $6,128 | 36.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 32 | 32 | $9,600 | $3,005 | 31.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 21 | 21 | $5,859 | $2,127 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 20 | $2,580 | $1,084 | 42.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 15 | 18 | $2,142 | $783.80 | 36.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 82 | 246 | $46,494 | $17,976 | 38.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 63 | 64 | $23,168 | $8,384 | 36.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 96 | 174 | $22,620 | $8,166 | 36.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 29 | 29 | $8,700 | $4,259 | 49.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 46 | 64 | $8,256 | $2,973 | 36.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 15 | 18 | $2,880 | $1,451 | 50.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 77 | 198 | $37,422 | $11,304 | 30.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 48 | 48 | $17,376 | $6,369 | 36.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 64 | 108 | $14,040 | $5,025 | 35.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 71 | $9,159 | $3,003 | 32.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 29 | 29 | $8,091 | $2,412 | 29.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 13 | $1,995 | $888.40 | 44.5% |
About Jennifer Jones
Jennifer Jones is a Psychiatric/Mental Health healthcare provider based in Alexandria, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/16/2015. The National Provider Identifier (NPI) number assigned to this provider is 1558752303.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jennifer Jones has received a total of $10,361 in payments from pharmaceutical and medical device companies, with $3,320 received in 2024. These payments were reported across 675 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($10,140).
As a Medicare-enrolled provider, Jones has provided services to 1,211 Medicare beneficiaries, totaling 2,459 services with total Medicare billing of $168,147. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Alexandria, LA
- Active Since 02/16/2015
- Last Updated 02/21/2017
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558752303
Products in Payments
- VRAYLAR (Drug) $1,607
- INGREZZA (Drug) $1,561
- REXULTI (Drug) $1,181
- CAPLYTA (Drug) $984.59
- ARISTADA (Drug) $779.66
- Auvelity (Drug) $537.64
- TRINTELLIX (Drug) $441.34
- INVEGA SUSTENNA (Drug) $370.15
- ABILIFY MAINTENA (Drug) $344.04
- Austedo XR (Drug) $318.13
- SPRAVATO (Drug) $314.35
- NUPLAZID (Drug) $263.72
- LATUDA (Drug) $250.87
- Azstarys (Drug) $196.53
- AUSTEDO (Drug) $113.64
- UZEDY (Drug) $109.01
- HETLIOZ (Drug) $96.67
- AJOVY (Biological) $89.38
- SUBLOCADE (Drug) $84.55
- QELBREE (Drug) $66.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Alexandria
Mrs. Monica Griffith, Aprn-Pmhnp-Bc, APRN-PMHNP-BC
Psychiatric/Mental Health — Payments: $8,493
Psychiatric/Mental Health $8,493
Kimberly Colston, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $7,215
Psychiatric/Mental Health $7,215
Mrs. Kimberly Rivers, Aprn, Pmhnp-Bc, APRN, PMHNP-BC
Psychiatric/Mental Health — Payments: $6,261
Psychiatric/Mental Health $6,261
Amy Paul, Aprn, APRN
Psychiatric/Mental Health — Payments: $6,253
Psychiatric/Mental Health $6,253
Alyssa Czudek, Aprn, Pmhnp-Bc, APRN, PMHNP-BC
Psychiatric/Mental Health — Payments: $5,944
Psychiatric/Mental Health $5,944
Lauri Haller, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $3,808
Psychiatric/Mental Health $3,808